欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1114/001
药品名称Noradrenaline Kabi 1 mg/ml concentrate for solution for infusion
活性成分
    • norepinephrine tartrate 1.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstraße 36 8055 Graz Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Belgium (BE)
      Noradrenaline Kabi 1 mg/ml concentraat voor oplossing voor infusie
    • Latvia (LV)
      Norepinephrine Kabi 1 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Netherlands (NL)
    • Lithuania (LT)
      Norepinephrine Kabi 1 mg/ml koncentratas infuziniam tirpalui
    • Ireland (IE)
    • Estonia (EE)
    • Hungary (HU)
    • Spain (ES)
    • Cyprus (CY)
      Noradrenaline/Kabi 1mg/ml concentrate for solution for infusion
    • Portugal (PT)
    • Czechia (CZ)
      Noradrenalin Fresenius Kabi
    • Italy (IT)
    • Romania (RO)
    • Greece (GR)
    • Slovakia (SK)
      Norepinephrine Kabi 1 mg/ml
    • Sweden (SE)
    • Slovenia (SI)
      Noradrenalin Kabi 1 mg/ml koncentrat za raztopino za infundiranje
    • Norway (NO)
      Noradrenalin Fresenius Kabi
    • Croatia (HR)
      Noradrenalin Kabi 1 mg/ml koncentrat za otopinu za infuziju
    • Germany (DE)
      Noradrenaline Kabi 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
    • Poland (PL)
      Noradrenaline Kabi
许可日期2021/03/19
最近更新日期2024/06/13
药物ATC编码
    • C01CA03 norepinephrine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase